MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)

Phase 2
Completed
Conditions
Lung Diseases
Lung Diseases, Obstructive
Chronic Obstructive Pulmonary Disease
Emphysema
First Posted Date
1999-10-28
Last Posted Date
2008-01-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000621

Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)

Phase 3
Completed
Conditions
Coronary Disease
Myocardial Ischemia
Cardiovascular Diseases
Myocardial Infarction
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-04-15
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000558

Prevention of Recurrent Venous Thromboembolism (PREVENT)

Phase 3
Completed
Conditions
Cardiovascular Diseases
Peripheral Vascular Diseases
Heart Diseases
Thromboembolism
Vascular Diseases
Venous Thromboembolism
First Posted Date
1999-10-28
Last Posted Date
2016-03-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000614

Azithromycin and Coronary Events Study (ACES)

Phase 3
Completed
Conditions
Coronary Disease
Heart Diseases
Myocardial Infarction
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-11-06
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000617

Management of Patent Ductus in Premature Infants

Phase 3
Completed
Conditions
Cardiovascular Diseases
Defect, Congenital Heart
Ductus Arteriosus, Patent
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2013-12-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000494

Prevention of Coronary Aneurysms in Kawasaki Syndrome

Phase 2
Completed
Conditions
Coronary Aneurysm
Heart Diseases
Mucocutaneous Lymph Node Syndrome
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2013-12-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000520

Cholesterol-Lowering Atherosclerosis Study (CLAS)

Phase 3
Completed
Conditions
Cerebral Arteriosclerosis
Arterial Occlusive Diseases
Cardiovascular Diseases
Coronary Disease
Carotid Artery Diseases
Coronary Arteriosclerosis
Cerebrovascular Disorders
Heart Diseases
Myocardial Ischemia
Atherosclerosis
First Posted Date
1999-10-28
Last Posted Date
2013-12-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000599

Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial

Phase 3
Completed
Conditions
Respiratory Distress Syndrome
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2013-12-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000570

Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up

Phase 2
Terminated
Conditions
Cardiovascular Diseases
Cerebrovascular Disorders
Heart Diseases
Vascular Diseases
Atherosclerosis
Carotid Artery Diseases
Intracranial Arteriosclerosis
First Posted Date
1999-10-28
Last Posted Date
2013-12-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000600

Coronary Artery Bypass Graft (CABG) Patch Trial

Phase 3
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Myocardial Ischemia
Arrhythmia
Coronary Disease
Ventricular Arrhythmia
Death, Sudden, Cardiac
Myocardial Infarction
First Posted Date
1999-10-28
Last Posted Date
2016-11-06
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000540
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy